1. Home
  2. BLKB vs OGN Comparison

BLKB vs OGN Comparison

Compare BLKB & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackbaud Inc.

BLKB

Blackbaud Inc.

HOLD

Current Price

$30.44

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.56

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLKB
OGN
Founded
1981
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
BLKB
OGN
Price
$30.44
$13.56
Analyst Decision
Hold
Hold
Analyst Count
3
5
Target Price
$50.00
$11.40
AVG Volume (30 Days)
892.6K
2.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
142.32
N/A
EPS
0.67
0.55
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$6.26
$0.45
Revenue Next Year
$4.25
$1.67
P/E Ratio
$44.93
$24.60
Revenue Growth
N/A
N/A
52 Week Low
$25.58
$5.69
52 Week High
$74.86
$13.60

Technical Indicators

Market Signals
Indicator
BLKB
OGN
Relative Strength Index (RSI) 55.83 73.60
Support Level $28.88 $10.05
Resistance Level $32.93 N/A
Average True Range (ATR) 1.48 0.06
MACD 0.61 -0.05
Stochastic Oscillator 86.73 78.57

Price Performance

Historical Comparison
BLKB
OGN

About BLKB Blackbaud Inc.

Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: